Shingen Nakamura Kumiko Kagawa Ryohei Sumitani Munenori Uemura Mamiko Takahashi Masami Iwasa Shiro Fujii Hirokazu Miki Masahiro Abe
10.2169/internalmedicine.56.8203
Intern Med
2017;56(15):2043-2047.
cd30 intravascular lymphoma malignant lymphoma superior vena cava syndrome
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28768978/
Lymphoma, Large B-Cell, Diffuse / diagnostic imaging Vena Cava, Superior
Lymphoma, Large B-Cell, Diffuse / diagnostic imaging Vena Cava, Superior Case Reports Aged Antibodies, Monoclonal, Murine-Derived / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Biopsy Cyclophosphamide / therapeutic use Doxorubicin / therapeutic use Humans Ki-1 Antigen / analysis Lymphoma, Large B-Cell, Diffuse / complications Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoma, Large B-Cell, Diffuse / pathology Male Neoplasm Recurrence, Local / drug therapy Prednisone / therapeutic use Remission Induction Rituximab Superior Vena Cava Syndrome / etiology Tomography, X-Ray Computed Vincristine / therapeutic use Antibodies, Monoclonal, Murine-Derived Ki-1 Antigen R-CHOP protocol Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone
PMC5577084
28768978
Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava
2017